News Agency
Men's Weekly

The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

  • Written by PR Newswire

NANJING, China, June 16, 2023 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs" or "Company") today announces that the phase I/II clinical trial application for LBL-033, an anti-MUC16/CD3 bispecific antibody, for the treatment of ovarian cancer and other malignant tumors, has been approved by the...

Read more: The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An...

Why Furniture Removalists Melbourne Are the Experts You Need for a Smooth Move

Moving house or office is one of life’s most demanding experiences, and one of the most difficult parts of the process is dealing with heavy, bulky, or delicate furniture. From couches and dining tables to antique cabinets and wardrobes, moving... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion